In this video, Deepak Bhatt, MD, MPH, overviews the findings from the eicosapentaenoic acid (EPA) analysis of the REDUCE-IT trial and what impact the results may have on the future of cardiovascular...
In this podcast, William R. Hiatt, MD, provides insight into a new subgroup analysis of the VOYAGER-PAD trial, which revealed whether adding clopidogrel to the rivaroxaban and aspirin regime of a patient...
In this podcast, Alexander Rothman, PhD, discusses his team's latest analysis of CANTOS, which evaluated whether interleukin-1β inhibition would reduce blood pressure, prevent incident...
A study team recently examined the risk of ischemic strokes and transient ischemic attacks among patients who discontinued vitamin K antagonist therapy. We spoke with lead authors Carlos Martinez, MD, MSc,...
Is obesity a causal risk factor for aortic stenosis? Researcher, Børge G. Nordestgaard, MD, DMSc, sheds light by answering our questions about his team’s latest study.
In this podcast, Peter Libby, MD, from Brigham and Women’s Hospital and Harvard Medical School, gives an overview of clonal hematopoiesis of indeterminate potential, how it relates to cardiovascular...
In this podcast, Rachana Kulkarni, MD, answers our questions about managing CVD in women who are pregnant, the challenges she has experienced when managing these patients, and more.
